Xvivo Perfusion AB's market cap is currently ―. The company's EPS TTM is $0.278; its P/E ratio is 93.80; Xvivo Perfusion AB is scheduled to report earnings on April 24, 2024, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22
Income Statement	-
Total Revenue	kr 140.62M	kr 131.51M	kr 96.83M	kr 94.29M	kr 92.65M
Gross Profit	kr 104.82M	kr 94.86M	kr 69.37M	kr 67.51M	kr 65.22M
EBIT	kr 11.21M	kr 18.81M	kr -4.66M	kr 4.14M	kr 4.62M
EBITDA	kr 11.21M	kr 18.81M	kr -4.66M	kr 4.14M	kr 4.62M
Net Income Common Stockholders	kr 14.18M	kr 734.00K	kr 5.40M	kr 7.53M	kr 4.76M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	kr 197.95M	kr 246.54M	kr 314.56M	kr 317.88M	kr 339.78M
Total Assets	kr 1.74B	kr 1.73B	kr 1.64B	kr 1.58B	kr 1.52B
Total Debt	kr 292.99M	kr 10.01M	kr 5.54M	kr 6.42M	kr 5.14M
Net Debt	kr 95.03M	kr -236.54M	kr -309.02M	kr -311.46M	kr -334.64M
Total Liabilities	kr 292.99M	kr 302.95M	kr 259.87M	kr 239.00M	kr 224.98M
Stockholders Equity	kr 1.45B	kr 1.43B	kr 1.38B	kr 1.35B	kr 1.30B
Cash Flow	-
Free Cash Flow	kr -12.43M	kr -109.16M	kr 16.97M	kr -1.56M	kr -9.35M
Operating Cash Flow	kr -12.43M	kr 21.79M	kr 16.97M	kr -1.56M	kr -9.35M
Investing Cash Flow	kr -33.53M	kr -77.05M	kr -33.72M	kr -34.48M	kr -52.37M
Financing Cash Flow	kr -2.49M	kr -2.80M	kr -1.62M	kr -556.00K	kr -1.86M

Currency in SEK

Xvivo Perfusion AB Earnings and Revenue History

Income Statement >

Xvivo Perfusion AB Debt to Assets

Balance Sheet >

Xvivo Perfusion AB Cash Flow

Cash Flow >

Xvivo Perfusion AB Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing